#Clinical Research #Healthtech #Health / Well-being
- Organoids
- Pre-clinical Studies
- Toxicity Analysis
- Efficacy Analysis
- Skin Technology
- Stem cells
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.
Discover >Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.
Discover >Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.
Discover >Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.
Discover >#Clinical Research #Healthtech #Health / Well-being
BioHive provides advanced analysis for dermatological products using innovative skin organoids derived from human stem cells, for toxicity and efficacy evaluations.
BACKGROUND
Cécile Nait Meddour developed an organoid model of Hidradenitis Suppurativa during her thesis, combining multiple technologies. Her expertise led her to found BioHive, becoming a reference in this field.
DESCRIPTION
BioHive offers analysis of dermatological formulations on innovative skin models derived from human stem cells.
These models, integrating various skin cell populations (including hair follicles), allow for precise toxicity and efficacy evaluations. Our R&D department develops custom organoids for specific pathologies, thus optimizing the screening of new molecules.
ACCOMPLISHMENTS / PARTNERSHIPS / HIGHLIGHTS
Laureate of the Shaker program (SkinOrga project) – 2022
Laureate of the Gene.iO program – 2023
Establishment of the company and development of BioHive’s first R&D programs in 2024.
COLLABORATIONs SOUGHT
We are looking for partnerships with cosmetic laboratories for compound analysis, and pharmaceutical laboratories interested in custom organoid models.
STRENGTHS: The only company offering skin organoids derived from iPSCs.
A young and dynamic team at the heart of R&D.
INNOVATION ASSETS: Robust results without interindividual variability.
Innovation ++: Holistic approach to different cell types.
In the same field